• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受多次输血患者的同种致敏

Allosensitization in patients receiving multiple blood transfusions.

作者信息

Sakhalkar V S, Roberts K, Hawthorne L M, McCaskill D M, Veillon D M, Caldito G C, Cotelingam J D

机构信息

Department of Pediatrics, Louisiana State University Health Science Center at Shreveport, Feist-Weiller Cancer Center, 1501 Kings Hwy., P.O. Box 33932, Shreveport, LA 71130-3932, USA.

出版信息

Ann N Y Acad Sci. 2005;1054:495-9. doi: 10.1196/annals.1345.072.

DOI:10.1196/annals.1345.072
PMID:16339705
Abstract

Extended antigen (C, E, K) matching decreased the incidence of alloantibody (alloAB) and autoantibody (autoAB) formation, in addition to eliminating transfusion reactions in the multiply transfused sickle cell disease patients. AlloAB formation possibly transforms the immune system into a hyperactive state leading to further and earlier alloAB and autoAB formation. However, additional CEK matching results in marked overuse of Rh-negative packed red blood cell (pRBC) units, 30 minutes' extra time of a skilled technologist, and 153 dollars extra CEK reagent cost per unit to find CEK-matched pRBCs for every transfusion for these multiply transfused patients.

摘要

除了消除多次输血的镰状细胞病患者的输血反应外,扩展抗原(C、E、K)匹配还降低了同种抗体(alloAB)和自身抗体(autoAB)形成的发生率。同种抗体的形成可能会使免疫系统转变为一种过度活跃的状态,从而导致更多更早地形成同种抗体和自身抗体。然而,额外的CEK匹配会导致Rh阴性浓缩红细胞(pRBC)单位的过度使用、熟练技术人员额外30分钟的时间以及为这些多次输血的患者每次输血寻找CEK匹配的pRBC时每单位额外153美元的CEK试剂成本。

相似文献

1
Allosensitization in patients receiving multiple blood transfusions.接受多次输血患者的同种致敏
Ann N Y Acad Sci. 2005;1054:495-9. doi: 10.1196/annals.1345.072.
2
Red cell exchange does not appear to increase the rate of allo- and auto-immunization in chronically transfused children with sickle cell disease.红细胞交换似乎不会增加慢性输血镰状细胞病患儿同种免疫和自身免疫的发生率。
Pediatr Blood Cancer. 2011 Aug;57(2):294-6. doi: 10.1002/pbc.22985. Epub 2011 Feb 4.
3
Antibody development in pediatric sickle cell patients undergoing erythrocytapheresis.小儿镰状细胞病患者行红细胞单采术后的抗体产生情况。
Pediatr Blood Cancer. 2010 Dec 1;55(6):1134-7. doi: 10.1002/pbc.22647.
4
Alloimmunization in sickle cell anemia in the era of extended red cell typing.镰状细胞贫血症中延长红细胞定型检测时代的同种免疫反应
Pediatr Blood Cancer. 2013 Sep;60(9):1487-91. doi: 10.1002/pbc.24530. Epub 2013 Mar 18.
5
Red cell alloantibodies in patients with haemoglobinopathies.血红蛋白病患者的红细胞同种抗体
Nouv Rev Fr Hematol (1978). 1994 Oct;36(5):363-6.
6
Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion.镰状细胞科威特阿拉伯患者接受红细胞输血后的红细胞同种免疫。
Transfusion. 2009 Aug;49(8):1649-54. doi: 10.1111/j.1537-2995.2009.02185.x.
7
Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.接受输血的镰状细胞病患者中红细胞同种抗体和自身抗体的临床意义。
Transfusion. 2002 Jan;42(1):37-43. doi: 10.1046/j.1537-2995.2002.00007.x.
8
Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia.输血治疗骨髓增生异常综合征或慢性粒单核细胞白血病患者的红细胞同种免疫。
Transfusion. 2013 Apr;53(4):710-5. doi: 10.1111/j.1537-2995.2012.03819.x. Epub 2012 Jul 31.
9
Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.镰状细胞病患者发生同种免疫和迟发性溶血性输血反应的风险。
Arch Intern Med. 1988 Nov;148(11):2485-9.
10
Red blood cell alloimmunization in sickle cell disease: prevalence in 2010.镰状细胞病中红细胞同种免疫:2010 年的流行率。
Transfusion. 2013 Apr;53(4):704-9. doi: 10.1111/j.1537-2995.2012.03796.x. Epub 2012 Jul 13.

引用本文的文献

1
Clinics and genetics of hyperhemolysis syndrome in patients with sickle cell disease.镰状细胞病患者高溶血综合征的临床特征与遗传学研究
Transfusion. 2025 May;65(5):992-1000. doi: 10.1111/trf.18232. Epub 2025 Apr 2.
2
Red Cell Alloimmunisation Among Sickle Cell Disease and Thalassemia Patients Following Rh- and K-Matched Red Cell Transfusion in Southwestern Saudi Arabia: A Multicenter Study.沙特阿拉伯西南部镰状细胞病和地中海贫血患者接受 Rh 和 K 配型红细胞输血后的红细胞同种免疫:一项多中心研究
Int J Gen Med. 2024 Jun 24;17:2855-2864. doi: 10.2147/IJGM.S444949. eCollection 2024.
3
When the available blood supply mismatches the needs of the patient.
当可用的血液供应与患者的需求不匹配时。
Blood Transfus. 2023 Sep;21(5):378-384. doi: 10.2450/2022.0166-22. Epub 2022 Nov 4.
4
Rh alloimmunization in chronically transfused patients with thalassemia receiving RhD, C, E, and K matched transfusions.对接受 RhD、C、E 和 K 匹配输血的慢性输血地中海贫血患者进行 Rh 同种免疫。
Blood Adv. 2021 Feb 9;5(3):737-744. doi: 10.1182/bloodadvances.2020003732.
5
Transfusion and Cellular Therapy in Pediatric Sickle Cell Disease.小儿镰状细胞病的输血和细胞治疗。
Clin Lab Med. 2021 Mar;41(1):101-119. doi: 10.1016/j.cll.2020.10.007. Epub 2020 Dec 24.
6
Rh antibodies as a result of altered Rh epitopes on transfused red cells: a case series of seven Brazilian patients.因输入的红细胞 Rh 表位改变导致的 Rh 抗体:7 例巴西患者的病例系列。
Blood Transfus. 2021 Sep;19(5):413-419. doi: 10.2450/2020.0073-20. Epub 2020 Oct 9.
7
American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support.美国血液学会 2020 年镰状细胞病指南:输血支持。
Blood Adv. 2020 Jan 28;4(2):327-355. doi: 10.1182/bloodadvances.2019001143.
8
Red Cell Transfusions in the Genomics Era.基因组时代的红细胞输注
Semin Hematol. 2019 Oct;56(4):236-240. doi: 10.1053/j.seminhematol.2019.11.001. Epub 2019 Nov 8.
9
Transfusion Support in Patients with Hematologic Disease: New and Novel Transfusion Modalities.血液系统疾病患者的输血支持:新的和新颖的输血方式。
Semin Hematol. 2019 Oct;56(4):227-228. doi: 10.1053/j.seminhematol.2019.11.007.
10
Diversity of RH and transfusion support in Brazilian sickle cell disease patients with unexplained Rh antibodies.巴西镰状细胞病患者中不明原因 Rh 抗体的 RH 多样性和输血支持。
Transfusion. 2019 Oct;59(10):3228-3235. doi: 10.1111/trf.15479. Epub 2019 Aug 13.